372 related articles for article (PubMed ID: 38516191)
1. Emerging roles of long non-coding RNAs in osteosarcoma.
Liao X; Wei R; Zhou J; Wu K; Li J
Front Mol Biosci; 2024; 11():1327459. PubMed ID: 38516191
[TBL] [Abstract][Full Text] [Related]
2. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma.
He J; Ling L; Liu Z; Ren X; Wan L; Tu C; Li Z
Cancer Cell Int; 2021 Jun; 21(1):313. PubMed ID: 34130697
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer.
Thapa R; Afzal O; Gupta G; Bhat AA; Almalki WH; Alzarea SI; Kazmi I; Altamimi ASA; Subramaniyan V; Thangavelu L; Singh SK; Dua K
Pathol Res Pract; 2023 Sep; 249():154736. PubMed ID: 37579591
[TBL] [Abstract][Full Text] [Related]
4. [Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma].
Kushlinskii NE; Fridman MV; Braga EA
Mol Biol (Mosk); 2020; 54(5):776-801. PubMed ID: 33009789
[TBL] [Abstract][Full Text] [Related]
5. Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer.
Lin S; Zhen Y; Guan Y; Yi H
Cancer Manag Res; 2020; 12():4181-4191. PubMed ID: 32581590
[TBL] [Abstract][Full Text] [Related]
6. Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.
Aryee DNT; Fock V; Kapoor U; Radic-Sarikas B; Kovar H
Cells; 2022 Apr; 11(8):. PubMed ID: 35455947
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics.
Fuloria S; Yadav G; Menon SV; Ali H; Pant K; Kaur M; Deorari M; Sekar M; Narain K; Kumar S; Fuloria NK
Pathol Res Pract; 2024 May; 259():155346. PubMed ID: 38781762
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1-related signaling pathways in osteosarcoma.
Farzaneh M; Najafi S; Anbiyaee O; Azizidoost S; Khoshnam SE
Clin Transl Oncol; 2023 Jan; 25(1):21-32. PubMed ID: 35790599
[TBL] [Abstract][Full Text] [Related]
9. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs in osteosarcoma.
Chen R; Wang G; Zheng Y; Hua Y; Cai Z
Oncotarget; 2017 Mar; 8(12):20462-20475. PubMed ID: 28103585
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNAs in osteosarcoma via various signaling pathways.
Han J; Shen X
J Clin Lab Anal; 2020 Jun; 34(6):e23317. PubMed ID: 32249459
[TBL] [Abstract][Full Text] [Related]
12. The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis.
Xu S; Gong Y; Yin Y; Xing H; Zhang N
Biomed Pharmacother; 2020 Jul; 127():110141. PubMed ID: 32334375
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β-catenin pathway.
Li Z; Zhao L; Wang Q
Am J Transl Res; 2016; 8(5):2385-93. PubMed ID: 27347346
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma.
Wu Y; Qian Z
Discov Med; 2019 Sep; 28(153):129-138. PubMed ID: 31926584
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs as potential biomarkers in osteosarcoma.
Fan L; Zhong Z; Lin Y; Li J
Front Genet; 2022; 13():1028477. PubMed ID: 36338952
[TBL] [Abstract][Full Text] [Related]
17. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
18. LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance.
Xiaotong S; Xiao L; Shiyu L; Zhiguo B; Chunyang F; Jianguo L
Front Genet; 2022; 13():1022155. PubMed ID: 36726721
[TBL] [Abstract][Full Text] [Related]
19. Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.
Zhang ZC; Tang C; Dong Y; Zhang J; Yuan T; Li XL
J Cancer; 2018; 9(1):71-80. PubMed ID: 29290771
[TBL] [Abstract][Full Text] [Related]
20. Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.
Ebrahimpour A; Sarfi M; Rezatabar S; Tehrani SS
Mol Cell Biochem; 2021 Jun; 476(6):2317-2335. PubMed ID: 33582947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
